Table 2. Clinicopathological characteristics of inflammatory and non-inflammatory patients with renal cancer before nephrectomy.
| C-reactive protein ⩽10 mg l−1 (n=34) median <6 mg l−1 | C-reactive protein>10 mg l−1 (n=30) median 35 mg l−1 | P-value | |
|---|---|---|---|
| Age group (⩽60/>60 years) | 17/17 | 18/12 | 0.426 |
| Sex (male/female) | 23/11 | 19/11 | 0.719 |
| T stage (1/2/3/4) | 19/2/11/2 | 8/2/10/10 | 0.005 |
| Tumour volume (cm3) | 64 (1–1331) | 179 (9–4864) | 0.123 |
| Fuhrman grade (1/2/3/4) | 5/11/9/6 | 3/5/12/7 | 0.193 |
| Operation (curative/cytoreductive) | 32/2 | 22/8 | 0.023 |
| ECOG-PS (0/1) | 32/2 | 21/9 | 0.011 |
| Haemoglobin (⩾12/<12 g dl−1) | 31/3 | 19/11 | 0.008 |
| White cell count | |||
| (<8.5/8.5–11.0/>11.0 109 l−1) | 26/8/0 | 22/5/3 | 0.344 |
| Lymphocyte percentage | |||
| (20–40/12.0–19.9/0–11.9%) | 26/6/2 | 17/9/4 | 0.100 |
| Albumin (⩾35/<35 g l−1) | 33/0 | 26/3 | 0.060 |
| Interleukin-6 (pg ml−1) | <2 (<2–20) | 16 (<2–142) | 0.001 |
| Interleukin-6 (⩽4/>4 pg ml−1) | 22/12 | 11/19 | 0.026 |
| Interleukin-10 (pg ml−1) | <4 (<4–66) | 8 (<4–35) | 0.013 |
| Interleukin-10 (⩽10/>10 pg ml−1) | 27/7 | 18/12 | 0.092 |
| Cancer–specific survival (months)a | 34.8 (32.6–37.1) | 28.1 (23.1–33.0) | 0.014 |
ECOG, Eastern Cooperative Oncology Group.
Median (range).
a
Mean (95%CI).